Literature DB >> 25561062

Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.

Saiyin Hexige1, Christine M Ardito-Abraham2, Yanhua Wu1, Youheng Wei1, Yuan Fang2, Xu Han2, Jianang Li2, Ping Zhou1, Qing Yi3, Anirban Maitra4,5, Jun O Liu6, David A Tuveson2, Wenhui Lou2, Long Yu1.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a nearly lethal neoplasm. It is a remarkably stroma-rich, vascular-poor and hypo-perfused tumour, which prevents efficient drug delivery. Paradoxically, the neoplastic cells have robust glucose uptake, suggesting that the microvasculature has adopted an alternative method for nutrient uptake and cellular trafficking. Using adapted thick tumour section immunostaining and three-dimensional (3D) construction imaging in human tissue samples, we identified an undiscovered feature of the mature microvasculature in advanced PDAC tumours; long, hair-like projections on the basal surface of microvessels that we refer to as 'basal microvilli'. Functionally, these basal microvilli have an actin-rich cytoskeleton and endocytic and exocytic properties, and contain glucose transporter-1 (GLUT-1)-positive vesicles. Clinically, as demonstrated by PET-CT, the tumour microvasculature with the longest and most abundant basal microvilli correlated with high glucose uptake of the PDAC tumour itself. In addition, these basal microvilli were found in regions of the tumour with low GLUT-1 expression, suggesting that their presence could be dependent upon the glucose concentration in the tumour milieu. Similar microvasculature features were also observed in a K-Ras-driven model of murine PDAC. Altogether, these basal microvilli mark a novel pathological feature of PDAC microvasculature. Because basal microvilli are pathological features with endo- and exocytic properties, they may provide a non-conventional method for cellular trafficking in PDAC tumours.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  3D imaging; basal microvilli; microvessels; neoplasia; pancreas

Mesh:

Substances:

Year:  2015        PMID: 25561062      PMCID: PMC5089710          DOI: 10.1002/path.4506

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  54 in total

Review 1.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

2.  Angiogenesis: a prognostic determinant in pancreatic cancer?

Authors:  Jill A van der Zee; Casper H J van Eijck; Wim C J Hop; Herman van Dekken; Bilyana M Dicheva; Ann L B Seynhaeve; Gerben A Koning; Alexander M M Eggermont; Timo L M ten Hagen
Journal:  Eur J Cancer       Date:  2011-09-28       Impact factor: 9.162

3.  Primary cilia regulates the directional migration and barrier integrity of endothelial cells through the modulation of hsp27 dependent actin cytoskeletal organization.

Authors:  Thomas J Jones; Ravi K Adapala; Werner J Geldenhuys; Chris Bursley; Wissam A AbouAlaiwi; Surya M Nauli; Charles K Thodeti
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

Review 4.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

5.  Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Laetitia Dahan; Jean-Luc Raoul; Yung-Jue Bang; Ivan Borbath; Catherine Lombard-Bohas; Juan Valle; Peter Metrakos; Denis Smith; Aaron Vinik; Jen-Shi Chen; Dieter Hörsch; Pascal Hammel; Bertram Wiedenmann; Eric Van Cutsem; Shem Patyna; Dongrui Ray Lu; Carolyn Blanckmeister; Richard Chao; Philippe Ruszniewski
Journal:  N Engl J Med       Date:  2011-02-10       Impact factor: 91.245

6.  18Fluorodeoxyglucose PET is prognostic of progression-free and overall survival in locally advanced pancreas cancer treated with stereotactic radiotherapy.

Authors:  Devin Schellenberg; Andy Quon; A Yuriko Minn; Edward E Graves; Pamela Kunz; James M Ford; George A Fisher; Karyn A Goodman; Albert C Koong; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038

Review 7.  Modelling oncogenic Ras/Raf signalling in the mouse.

Authors:  Florian A Karreth; David A Tuveson
Journal:  Curr Opin Genet Dev       Date:  2009-02-07       Impact factor: 5.578

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

9.  Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.

Authors:  A Couvelard; D O'Toole; H Turley; R Leek; A Sauvanet; C Degott; P Ruszniewski; J Belghiti; A L Harris; K Gatter; F Pezzella
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

10.  Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery.

Authors:  Chen-Xin Dai; Qiang Gao; Shuang-Jian Qiu; Min-Jie Ju; Ming-Yan Cai; Yong-Feng Xu; Jian Zhou; Bo-Heng Zhang; Jia Fan
Journal:  BMC Cancer       Date:  2009-12-01       Impact factor: 4.430

View more
  10 in total

1.  Feeding cancer's sweet tooth: specialized tumour vasculature shuttles glucose in pancreatic ductal adenocarcinoma.

Authors:  Andrew C Dudley; Victoria L Bautch
Journal:  J Pathol       Date:  2015-03-30       Impact factor: 7.996

2.  β-Catenin signaling is essential for mammalian larynx recanalization and the establishment of vocal fold progenitor cells.

Authors:  Vlasta Lungova; Jamie M Verheyden; Xin Sun; Susan L Thibeault
Journal:  Development       Date:  2018-02-16       Impact factor: 6.868

3.  BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity.

Authors:  Hexige Saiyin; Ning Na; Xu Han; Yuan Fang; Yanhua Wu; Wenhui Lou; Xianmei Yang
Journal:  Oncotarget       Date:  2017-07-04

4.  LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.

Authors:  Lixiang Ma; Hexige Saiyin
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

5.  Evaluation of the antitumor mechanism of antibody-drug conjugates against tissue factor in stroma-rich allograft models.

Authors:  Ryo Tsumura; Shino Manabe; Hiroki Takashima; Yoshikatsu Koga; Masahiro Yasunaga; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2019-08-29       Impact factor: 6.716

Review 6.  Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer.

Authors:  Veronique L Veenstra; Andrea Garcia-Garijo; Hanneke W van Laarhoven; Maarten F Bijlsma
Journal:  Cancers (Basel)       Date:  2018-01-27       Impact factor: 6.639

7.  The physiological characteristics of the basal microvilli microvessels in pancreatic cancers.

Authors:  Lixiang Ma; Xu Han; Jichun Gu; Ji Li; Wenhui Lou; Chen Jin; Hexige Saiyin
Journal:  Cancer Med       Date:  2020-06-02       Impact factor: 4.452

Review 8.  Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?

Authors:  Mohamed Islam Delma
Journal:  Cureus       Date:  2020-10-12

9.  Basal microvilli define the metabolic capacity and lethal phenotype of pancreatic cancer.

Authors:  Xu Han; Lixiang Ma; Jichun Gu; Dansong Wang; Ji Li; Wenhui Lou; Hexige Saiyin; Deliang Fu
Journal:  J Pathol       Date:  2021-01-22       Impact factor: 7.996

Review 10.  Hydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate.

Authors:  Chun-Yi Chang; Chien-Chi Lin
Journal:  Bioengineering (Basel)       Date:  2021-03-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.